Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-055543

Director sold 18,279 shares at an average $16.01 ($292,670)

  • Director acquired 18,279 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

CHESS ROBERT · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-08 Exercise or conversion : show line 1 in the form +8,000 $13.80 $110,400 282,273 D
2021-09-08 Sale : show line 2 in the form −8,000 $16.00 $128,000 274,273 D
2021-09-09 Exercise or conversion : show line 3 in the form +10,279 $13.80 $141,850 284,552 D
2021-09-09 Sale : show line 4 in the form −10,279 $16.02 $164,670 274,273 D
Open-market sales · 18,279 sh · avg $16.01 · $292,670

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-09-08 Exercise or conversion : show line 5 in the form Common Stock −8,000 10,279 D
2021-09-09 Exercise or conversion : show line 6 in the form Common Stock −10,279 0 D
Loading xslF345X03/doc4.xml…